Skip to main content
Home
About Us
Overview
Senior Leadership
Board of Directors
Advisory Board
Our Medicines
Overview
Talicia®
Aemcolo®
Expanded Access
Our Programs
Pipeline
Pipeline
Opaganib
Acute Radiation Syndrome
COVID-19
RHB-107
COVID-19
RHB-102
Oncology Support
Gastroenteritis & Gastritis
IBS-D
RHB-204
RHB-104
Crohn's disease
Multiple Sclerosis
Medical Grant & Investigator Initiated Study Requests
Investigator Initiated Study Requests
Medical Grant/Sponsorship
Medical Information
News
Investors
Overview
Events & Presentations
Press Releases
Financial Filings
Quarterly Reports
Annual Reports
SEC Filings
Stock Information
Stock Information
Analyst Coverage
Corporate Governance
Governance Documents
Partnering
Careers
Overview
Benefits
Contact
Contact Us
Email Alerts
Event Details
Home
About Us
Overview
Senior Leadership
Board of Directors
Advisory Board
Our Medicines
Overview
Talicia®
Aemcolo®
Expanded Access
Our Programs
Pipeline
Pipeline
Opaganib
Acute Radiation Syndrome
COVID-19
RHB-107
COVID-19
RHB-102
Oncology Support
Gastroenteritis & Gastritis
IBS-D
RHB-204
RHB-104
Crohn's disease
Multiple Sclerosis
Medical Grant & Investigator Initiated Study Requests
Investigator Initiated Study Requests
Medical Grant/Sponsorship
Medical Information
News
Investors
Overview
Events & Presentations
Press Releases
Financial Filings
Quarterly Reports
Annual Reports
SEC Filings
Stock Information
Stock Information
Analyst Coverage
Corporate Governance
Governance Documents
Partnering
Careers
Overview
Benefits
Contact
Contact Us
Email Alerts
BIO CEO & Investor Conference
from February 8, 2016 to February 9, 2016
Waldorf Astoria, New York
Speaker(s):
Dror Ben-Asher
,
CEO
RedHill will present on Tuesday, Feb.. 9th, at 4:00 pm, at the Park North room.
Add to Calendar
Add to Apple Calendar
Add to Google Calendar
Add to Microsoft Outlook
Add to iCalendar